Profile
Daniel E.
Couto is currently the Chief Operating Officer at Vedanta Biosciences, Inc. He previously worked as a Director at ImmuCell Corp., Sumitomo Pharma America, Inc., AFG Biosolutions, Inc., rEVO Biologics, Inc., and as the Vice President-Commercial Manufacturing Operations at Organon Pharma (UK) Ltd. He also served as the Senior Vice President-Product Development at ContraFect Corp.
from 2014 to 2016.
Couto completed his undergraduate degree from Rensselaer Polytechnic Institute.
Daniel Couto active positions
| Companies | Position | Start |
|---|---|---|
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Chief Operating Officer | 2019-09-30 |
Former positions of Daniel Couto
| Companies | Position | End |
|---|---|---|
| CONTRAFECT CORPORATION | Corporate Officer/Principal | 2016-04-21 |
AFG Biosolutions, Inc.
AFG Biosolutions, Inc. Pharmaceuticals: MajorHealth Technology Develops medical defenses against bio-terrorist agents | Director/Board Member | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Director/Board Member | - |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Corporate Officer/Principal | - |
| IMMUCELL CORPORATION | Director/Board Member | - |
Training of Daniel Couto
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
ImmuCell Corp.
ImmuCell Corp. BiotechnologyHealth Technology Develops and provides products for cattle health | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
AFG Biosolutions, Inc.
AFG Biosolutions, Inc. Pharmaceuticals: MajorHealth Technology Develops medical defenses against bio-terrorist agents | Health Technology |
Rensselaer Polytechnic Institute
Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales women's health products | Health Technology |
ContraFect Corp.
ContraFect Corp. BiotechnologyHealth Technology Engages in discovery and development of direct lytic agents for life-threatening & drug-resistant infectious diseases | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
- Stock Market
- Insiders
- Daniel Couto
















